These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 7683932

  • 1. In vivo effects of interleukin-6 on thrombopoiesis.
    Stahl CP, Zucker-Franklin D.
    Blood; 1993 May 15; 81(10):2819-20. PubMed ID: 7683932
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates.
    Stahl CP, Winton EF, Monroe MC, Haff E, Holman RC, Myers L, Liehl E, Evatt BL.
    Blood; 1992 Nov 15; 80(10):2479-85. PubMed ID: 1421371
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multiple in vivo effects of interleukin-3 and interleukin-6 on murine megakaryocytopoiesis.
    Carrington PA, Hill RJ, Stenberg PE, Levin J, Corash L, Schreurs J, Baker G, Levin FC.
    Blood; 1991 Jan 01; 77(1):34-41. PubMed ID: 1984801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of human interleukin-6 on megakaryocyte development and thrombocytopoiesis in primates.
    Stahl CP, Zucker-Franklin D, Evatt BL, Winton EF.
    Blood; 1991 Sep 15; 78(6):1467-75. PubMed ID: 1884016
    [Abstract] [Full Text] [Related]

  • 12. In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates.
    Geissler K, Valent P, Bettelheim P, Sillaber C, Wagner B, Kyrle P, Hinterberger W, Lechner K, Liehl E, Mayer P.
    Blood; 1992 Mar 01; 79(5):1155-60. PubMed ID: 1536942
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
    Harker LA, Marzec UM, Kelly AB, Cheung E, Tomer A, Nichol JL, Hanson SR, Stead RB.
    Blood; 1997 Jan 01; 89(1):155-65. PubMed ID: 8978288
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.
    Briggs M, Adams JA, Brereton ML, Burgess R, Hyde K, Lenehan H, Yin JA.
    Br J Haematol; 2001 Dec 01; 115(3):563-8. PubMed ID: 11736936
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Platelet growth factors: potential impact on transfusion medicine.
    Kuter DJ, Cebon J, Harker LA, Petz LD, McCullough J.
    Transfusion; 1999 Mar 01; 39(3):321-32. PubMed ID: 10204598
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.